Klaus Brandenburg Selected Research

Klaus Brandenburg Research Topics

Disease

30	Sepsis (Septicemia) 10/2023 - 01/2006
17	Infections 02/2022 - 01/2007
15	Septic Shock (Toxic Shock Syndrome) 12/2022 - 10/2004
14	Inflammation (Inflammations) 10/2023 - 06/2009
11	Bacterial Infections (Bacterial Infection) 12/2022 - 10/2007
3	Bacteremia 03/2021 - 03/2013
3	Endotoxemia 03/2021 - 03/2013
3	Shock 01/2018 - 09/2010
3	Wounds and Injuries (Trauma) 01/2018 - 01/2018
2	Soft Tissue Infections 12/2022 - 01/2018
2	Gram-Negative Bacterial Infections 01/2021 - 01/2015
2	Multiple Organ Failure (MODS) 01/2018 - 09/2010
2	Necrosis 10/2014 - 09/2007
2	Communicable Diseases (Infectious Diseases) 05/2011 - 10/2008
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2023
1	COVID-19 10/2023
1	Cutaneous Leishmaniasis 11/2022
1	Wound Infection (Wound Infections) 03/2021
1	Hypercholesterolemia 01/2021
1	Fatty Liver 01/2021
1	Insulin Resistance 01/2021
1	Obesity 01/2021
1	Proteinuria 01/2021
1	Liver Diseases (Liver Disease) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Hemorrhagic Shock 01/2018
1	Leukopenia 01/2017
1	Hyperlactatemia 01/2017
1	Hypothermia 01/2017
1	Hyperglycemia 01/2017
1	Cardiomyopathies (Cardiomyopathy) 11/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2016
1	Immune System Diseases (Immune Disorders) 09/2016
1	Pain (Aches) 01/2016
1	Tuberculosis (Tuberculoses) 08/2010
1	Plague (Bubonic Plague) 06/2010
1	Meningococcal Infections 01/2007
1	Meningitis 01/2007
1	Melioidosis 03/2006

Drug/Important Bio-Agent (IBA)

24	Peptides (Polypeptides)IBA 12/2022 - 09/2007
23	EndotoxinsIBA 10/2023 - 10/2004
19	LipopolysaccharidesIBA 10/2023 - 10/2004
16	Antimicrobial PeptidesIBA 03/2021 - 10/2007
13	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 09/2010
8	Pep19-2.5 peptideIBA 12/2022 - 01/2013
6	Virulence Factors (Pathogenicity Factors)IBA 01/2017 - 09/2007
5	CytokinesIBA 10/2023 - 09/2010
5	Lipoproteins (Lipoprotein)IBA 02/2021 - 09/2015
4	Pep19-4LFIBA 12/2022 - 11/2016
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2021 - 06/2009
3	Adenosine Monophosphate (AMP)IBA 03/2021 - 02/2015
3	InflammasomesIBA 01/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2007
3	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018 - 01/2015
3	Heparitin Sulfate (Heparan Sulfate)IBA 01/2015 - 06/2012
2	Peptide Hydrolases (Proteases)FDA Link 03/2018 - 06/2010
2	Antimicrobial Cationic PeptidesIBA 01/2018 - 04/2007
2	Toll-Like Receptor 4IBA 01/2017 - 01/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 03/2006
2	Adenosine Triphosphate (ATP)IBA 01/2017 - 11/2016
2	Local Anti-Infective Agents (Antiseptics)IBA 03/2013 - 09/2010
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 10/2023
1	Colistin (Coly-Mycin)FDA Link 02/2022
1	Polysaccharides (Glycans)IBA 03/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	CathelicidinsIBA 01/2018
1	AntitoxinsIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2017
1	CaspasesIBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2016
1	Pattern Recognition ReceptorsIBA 09/2016
1	LigandsIBA 09/2016
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2015
1	heparanaseIBA 01/2015
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2015
1	Therapeutic UsesIBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2013
1	Erythromycin (Erycette)FDA LinkGeneric 01/2011
1	LipopeptidesIBA 08/2010
1	PlasminogenIBA 06/2010
1	Phospholipids (Phosphatides)FDA LinkGeneric 06/2009
1	Lipid AIBA 10/2008
1	endotoxin binding proteinsIBA 10/2007
1	factor AIBA 09/2007
1	antilipopolysaccharide factor (Limulus)IBA 09/2007
1	ExotoxinsIBA 03/2006
1	rhamnolipidIBA 03/2006

Therapy/Procedure

8	Therapeutics 10/2023 - 01/2006
3	Critical Care (Surgical Intensive Care) 05/2016 - 01/2013
2	Punctures 03/2013 - 01/2013
2	Ligation 03/2013 - 01/2013
1	Resuscitation 01/2018
1	Oral Administration 02/2015